Colorectal Carcinoma
|
0.310 |
GeneticVariation
|
disease |
UNIPROT |
|
|
|
Schizophrenia
|
0.310 |
GeneticVariation
|
disease |
BEFREE |
Therefore, we investigated the contribution of genetic variations of ADORA1 to the pathophysiological mechanisms of Japanese schizophrenia patients.
|
19820430 |
2009 |
Asthma
|
0.130 |
GeneticVariation
|
disease |
GWASCAT |
Genetic Architectures of Childhood- and Adult-Onset Asthma Are Partly Distinct.
|
30929738 |
2019 |
Asthma
|
0.130 |
GeneticVariation
|
disease |
GWASCAT |
Shared genetics of asthma and mental health disorders: a large-scale genome-wide cross-trait analysis.
|
31619474 |
2019 |
Asthma
|
0.130 |
GeneticVariation
|
disease |
GWASCAT |
Detection and interpretation of shared genetic influences on 42 human traits.
|
27182965 |
2016 |
Respiratory Tract Diseases
|
0.100 |
GeneticVariation
|
group |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Waist-Hip Ratio
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Childhood asthma
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Shared and distinct genetic risk factors for childhood-onset and adult-onset asthma: genome-wide and transcriptome-wide studies.
|
31036433 |
2019 |
Childhood asthma
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genetic Architectures of Childhood- and Adult-Onset Asthma Are Partly Distinct.
|
30929738 |
2019 |
Systolic Pressure
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits.
|
30224653 |
2018 |
Anxiety
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Apart from the almost completely linked ADORA2A SNP rs3761422, no other of eight ADORA2A and seven ADORA1 SNPs studied were found to be clearly associated with effects of caffeine on anxiety, alertness, or headache.
|
20520601 |
2010 |
Anxiety Disorders
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Apart from the almost completely linked ADORA2A SNP rs3761422, no other of eight ADORA2A and seven ADORA1 SNPs studied were found to be clearly associated with effects of caffeine on anxiety, alertness, or headache.
|
20520601 |
2010 |
Bipolar Disorder
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Our data suggest that genetically determined variation of the A1AR and its two promoters do not play a major role in the development of bipolar affective disorder.
|
9514582 |
1998 |
Headache
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
Apart from the almost completely linked ADORA2A SNP rs3761422, no other of eight ADORA2A and seven ADORA1 SNPs studied were found to be clearly associated with effects of caffeine on anxiety, alertness, or headache.
|
20520601 |
2010 |
Gilles de la Tourette syndrome
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The aim of the study was to analyze the association of two polymorphisms, rs2228079 in ADORA1 and rs5751876 in ADORA2A, with the risk of GTS and co-morbid disorders.
|
26317759 |
2015 |
Tremor
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
We tested mice with essential-like tremor using current drug therapies that alleviate symptoms in essential tremor patients (primidone, propranolol, and gabapentin) and several candidates hypothesized to reduce tremor, including ethanol; the noncompetitive N-methyl-D-aspartate receptor antagonist MK-801; the adenosine A1 receptor agonist 2-chloro-N6-cyclopentyladenosine (CCPA); the GABA(A) receptor modulators diazepam, allopregnanolone, and Ro15-4513; and the L-type Ca2+ channel antagonist nitrendipine.
|
15765150 |
2005 |
Parkinsonian Disorders
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Mutation in ADORA1 identified as likely cause of early-onset parkinsonism and cognitive dysfunction.
|
27134041 |
2016 |
Impaired cognition
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Mutation in ADORA1 identified as likely cause of early-onset parkinsonism and cognitive dysfunction.
|
27134041 |
2016 |
Akathisia
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
Haplotype analysis showed an association between ADORA1 CTCAACG haplotype and overall psychopathological symptoms (p = 0.019), positive psychopathological symptoms (p = 0.021), and akathisia (p = 0.028).
|
27195966 |
2016 |
MAJOR AFFECTIVE DISORDER 2
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Our data suggest that genetically determined variation of the A1AR and its two promoters do not play a major role in the development of bipolar affective disorder.
|
9514582 |
1998 |
MAJOR AFFECTIVE DISORDER 1
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Our data suggest that genetically determined variation of the A1AR and its two promoters do not play a major role in the development of bipolar affective disorder.
|
9514582 |
1998 |
MAJOR AFFECTIVE DISORDER 4
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Our data suggest that genetically determined variation of the A1AR and its two promoters do not play a major role in the development of bipolar affective disorder.
|
9514582 |
1998 |
MAJOR AFFECTIVE DISORDER 6
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Our data suggest that genetically determined variation of the A1AR and its two promoters do not play a major role in the development of bipolar affective disorder.
|
9514582 |
1998 |
MAJOR AFFECTIVE DISORDER 7
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Our data suggest that genetically determined variation of the A1AR and its two promoters do not play a major role in the development of bipolar affective disorder.
|
9514582 |
1998 |
MAJOR AFFECTIVE DISORDER 8
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Our data suggest that genetically determined variation of the A1AR and its two promoters do not play a major role in the development of bipolar affective disorder.
|
9514582 |
1998 |